Get started
Author

Melitta Beatrice Köpke

Observed names: B M Köpke, M B Köpke, M Köpke, M. B. Köpke, M. Köpke, MB Köpke, Melitta B Köpke, Melitta B. Köpke, Melitta Koepke, Melitta Köpke, Melitta M. Köpke
Observed institutions: University of Augsburg, German Cancer Research Center, Heidelberg University, University of Würzburg, University Hospital Augsburg, University Hospital Heidelberg, Ostalb-Klinikum Aalen, National Center for Tumor Diseases, Frauenklinik Heidelberg
ORCID: 0000-0002-6463-1499
Observed ORCID: 0000-0002-6463-1499
OpenAlex ID: A5025550886
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
2018 · André Hennigs, Melitta Köpke, et al. · Breast Cancer Research and Treatment · 30
The Role of Chemokines in Cervical Cancers
2021 · Fabian Garrido, Carl Mathis Wild, et al. · Medicina · 26
PDF
Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study
2018 · André Hennigs, Fabian Riedel, et al. · Annals of Surgical Oncology · 19
Elderly and Patients with Large Breast Volume Have an Increased Risk of Seroma Formation after Mastectomy—Results of the SerMa Pilot Study
2023 · Melitta Beatrice Köpke, Carl Mathis Wild, et al. · Cancers · 13
PDF
Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery
2023 · Nicole Pochert, Mariella Schneider, et al. · Archives of Gynecology and Obstetrics · 12
PDF
Prognostic Relevance of Tumor-Infiltrating Immune Cells in Cervix Squamous Cell Carcinoma
2023 · Carl Mathis Wild, Fabian Garrido, et al. · Cancers · 9
PDF
Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023
2023 · Melitta M. Köpke, Bahriye Aktas, et al. · Current Opinion in Obstetrics & Gynecology · 9
Attitudes of Nurses Toward Disability and Treatment in Space-Occupying Middle Cerebral Artery Stroke
2018 · for the IGNITE Study Group (Initiative of German NeuroIntensive Trial Engagement), Hermann Neugebauer, et al. · Neurocritical Care · 8
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study
2022 · Linn Woelber, Monika Hampl, et al. · Cancers · 7
PDF
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients
2022 · Wanting Shao, Melitta B. Köpke, et al. · Cells · 6
PDF
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registry
2026 · Manuel Hörner, Andreas Hartkopf, et al. · npj Breast Cancer · 5
PDF
Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
2023 · Mariella Schneider, Melitta B. Köpke, et al. · Cancers · 4
PDF
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial
2026 · Manuel Hörner, Lara M. Tretschock, et al. · Breast Cancer Research and Treatment · 2
PDF
Significant Increase of Patient Information and Satisfaction with Longer Initial Consultation Duration in Breast Cancer - First Results of the WAVES Study
2025 · Nina Ditsch, Melitta B. Köpke, et al. · Fortune Journal of Health Sciences · 2
Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer
2022 · Melitta B. Köpke, Marie-Christine Chateau, et al. · Cancers · 2
PDF
Macrophage polarization is associated with postoperative seroma development in breast cancer in the SerMa pilot cohort
2025 · Felicitas Magdalena Schneider, Nicole Pochert, et al. · Scientific Reports · 1
„Weitblick“ – über Anspruch und Wirklichkeit der Weiterbildung in Bayern
2025 · Melitta Beatrice Köpke, Yvonne Link, et al. · Geburtshilfe und Frauenheilkunde · 1
Altersabhängige Bedürfnisse zur Arzt-Patienten-Kommunikation bei Brustkrebs: Erkenntnisse aus der WAVES-Studie
2026 · N Ditsch, M B Köpke, et al. · Geburtshilfe und Frauenheilkunde
MELODY (MEthods for LOcalization of Different tYpes of breast lesions) A prospective non-interventional multicenter cohort study to evaluate different methods for localization of malignant breast lesions (EUBREAST-04/iBRA-NET, NCT05559411)
2026 · G Schultek, M Banys-Paluchowski, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Non-Titanised Compared to Titanised Polypropylene Meshes Induce a Pro-Inflammatory and Anti-Angiogenic Response in Fibroblast Co-Cultures
2026 · Oleksii Protsepko, Philipp Voisard, et al. · Cell Biochemistry and Biophysics
PDF
Abstract PS5-08-17: Melody: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (Eubreast-4 / iBra-net, Nct 05559411)
2026 · J. Ryu, T. Kühn, et al. · Clinical Cancer Research
A low nuclear-to-cytoplasmic ratio of VDR expression is an independent prognostic marker in breast cancer.
2025 · Charlotte Schubert, Theresa Vilsmaier, et al. · PubMed
Investigating the Importance of Patient-physician-communication for Successful Treatment of Metastatic Breast Cancer: the Waves Study
2025 · Eva Schumacher-Wulf, Melitta Beatrice Köpke, et al. · The Breast
Prognostic Impact of Stromal Progesterone Receptor A Expression in Cervical Squamous Cell Carcinoma
2025 · Carl Mathis Wild, Christian Dannecker, et al. · Geburtshilfe und Frauenheilkunde
Tumor-associated macrophage infiltration in triple-negative breast cancer investigated in patient-derived xenograft (PDX) models
2025 · Luise Jahn, Carl Mathis Wild, et al. · Geburtshilfe und Frauenheilkunde
Works count: 48
Citation count: 156
H-index: 8
I10-index: 5
Year
Topic
Type